VIBOZILIMOD TRIAL FAILURE
Sun Pharma Advanced Research shares tank 20% after psoriasis drug fails Phase 2 trialsSun Pharma Advanced Research Company (SPARC) psoriasis drug, Vibozilimod (SCD-044), failed to meet primary endpoints in Phase 2 trials for ...
- Load More